Equine CNP antibody and antigen (recombinant protein)
Diagnostic anti-Equine CNP antibodies pairs and antigen for animal health (animal Equine/Horse cardiovascular disease) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Equine disease testing products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-EQU-CNP-Ag01 | Equine CNP | $3090.00 |
GMP-EQU-CNP-Ab01 | Anti-Equine CNP mouse monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-CNP-Ab02 | Anti-Equine CNP mouse monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-CNP-Ab03 | Anti-Equine CNP human monoclonal antibody (mAb) | $3090.00 |
GMP-EQU-CNP-Ab04 | Anti-Equine CNP human monoclonal antibody (mAb) | $3090.00 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. | GMP-EQU-CNP-Ag01 |
Product Name | Equine CNP |
Target/Biomarker | Equine CNP |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Equine CNP antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CNP level test of animal Equine/Horse with cardiovascular disease. |
Tag | His | Reconized/Reactive Specics | Equine CNP |
Product description | Recombinant Equine CNP protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-EQU-CNP-Ab01,GMP-EQU-CNP-Ab02 |
Target/Biomarker | Equine CNP |
Product Name | Anti-Equine CNP mouse monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Equine CNP antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CNP antibodies in Equine CNP level test of animal Equine/Horse with cardiovascular disease. |
Product description | Anti-Equine CNP mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CNP antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. | GMP-EQU-CNP-Ab03,GMP-EQU-CNP-Ab04 |
Target/Biomarker | Equine CNP |
Product Name | Anti-Equine CNP human monoclonal antibody (mAb) |
Expression platform | CHO |
Isotypes | Human lgG1 |
Bioactivity validation | Recombinant Equine CNP antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CNP antibodies in Equine CNP level test of animal Equine/Horse with cardiovascular disease. |
Product description | Anti-Equine CNP mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker Information
In horses, CNP demonstrates diverse roles beyond its cardiovascular effects. Here are some additional perspectives on Equine CNP:
a) Vascular Development: CNP plays a crucial role in vascular development and angiogenesis during embryonic development in horses. It contributes to the formation of blood vessels by promoting endothelial cell proliferation, migration, and tube formation.
b) Skeletal Growth: CNP is involved in regulating the growth and development of long bones through its effects on the growth plates in horses. It modulates chondrocyte proliferation, differentiation, and matrix synthesis in the growth plates, influencing bone growth and skeletal development.
c) Reproductive System: CNP has been identified in the reproductive tissues of horses, including the ovaries and testes. It may play a role in follicular development, ovulation, and spermatogenesis, although further research is needed to fully understand its functions in the reproductive system of horses.
d) Stress Response: CNP levels can be influenced by stress and certain pathological conditions in horses. Monitoring CNP in horses exposed to stressful situations or experiencing conditions like heart disease can provide insights into the physiological responses to stress and pathological stress-related changes.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.